Search results
Results from the WOW.Com Content Network
The prostate is located right beneath the bladder, and surrounds the urethral sphincter. Any damage to the sphincter or surrounding muscles and nerves can lead to urinary incontinence. The problem is most severe in the first 6 to 12 months after treatment, but usually resolves on its own within this time. [ 17 ]
[1] [2] Diagnosis is typically based on measuring the amount of urine in the bladder after urinating. [1] Treatment is typically with a catheter either through the urethra or lower abdomen. [1] [3] Other treatments may include medication to decrease the size of the prostate, urethral dilation, a urethral stent, or surgery. [1]
The results of the study did not provide sufficient evidence on the quality of life in individuals diagnosed with prostate cancer, including urinary tract symptoms and prostatic congestion. [ 14 ] Urinary tract cysts – A benign condition of the urinary bladder in which there is a change of the bladder mucosa-associated cysts formation.
Surgical treatment of LUTS can include: Ablation procedures – used in treating both bladder tumours [22] and bladder outlet obstruction, such as prostate conditions. [23] Bladder-neck incision (BNI) Removal of the prostate – open, robotic, and endoscopic techniques are used. Stenting of the prostate [24] and urethra.
Bleeding may be reduced by pre-treatment with an anti-androgen such as finasteride [6] [7] [8] or flutamide. [citation needed] Clot retention and clot colic. The blood released from the resected prostate may become stuck in the urethra and can cause pain and urine retention. Bladder wall injury, such as perforation (rare).
The bladder is an organ that stores urine until it is released from the body. Several conditions can affect the bladder including urinary tract infections, bladder stones, bladder cancer, overactive bladder, cystitis, interstitial cystitis, abscess, fistula, and urinary incontinence. [4] [5] [1]
Alfuzosin, sold under the brand name Uroxatral among others, is a medication of the α 1 blocker class. It is used to treat benign prostatic hyperplasia (BPH). [1]As an antagonist of the α 1-adrenergic receptor, it works by relaxing the muscles in the prostate and bladder neck, making urination easier.
Benign prostatic hyperplasia (BPH), also called prostate enlargement, is a noncancerous increase in size of the prostate gland. [1] Symptoms may include frequent urination, trouble starting to urinate, weak stream, inability to urinate, or loss of bladder control. [1]